chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine

chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine

;Xiaosong Li;Min Min;Nan Du;Ying Gu;Tomas Hode;Mark Naylor;Dianjun Chen;Robert E. Nordquist;Wei R. Chen
Applied Surface Science 2013 Vol. 2013 pp. -
210
li2013clinicalchitin,

Abstract

With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine. In this paper, the adjuvant properties of chitin and chitosan were discussed, and some detailed information about glycated chitosan and chitosan nanoparticles was also presented to illustrate the trend for future development.

Citation

ID: 230984
Ref Key: li2013clinicalchitin,
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
230984
Unique Identifier:
10.1155/2013/387023
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet